Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
PSAP (human)
p Phosphorylation
ac Acetylation
me Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
ub Ubiquitination
sm Sumoylation
ne Neddylation
gl O-GlcNAc
ga O-GalNAc
pa Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage
sc Succinylation

Overview
PSAP The lysosomal degradation of sphingolipids takes place by the sequential action of specific hydrolases. Some of these enzymes require specific low-molecular mass, non-enzymic proteins: the sphingolipids activator proteins (coproteins). Defects in PSAP are the cause of combined saposin deficiency (CSAPD); also known as prosaposin deficiency. CSAPD is due to absence of all saposins, leading to a fatal storage disorder with hepatosplenomegaly and severe neurological involvement. Defects in PSAP saposin-B region are the cause of leukodystrophy metachromatic due to saposin-B deficiency (MLD- SAPB). MLD-SAPB is an atypical form of metachromatic leukodystrophy. It is characterized by tissue accumulation of cerebroside-3-sulfate, demyelination, periventricular white matter abnormalities, peripheral neuropathy. Additional neurological features include dysarthria, ataxic gait, psychomotr regression, seizures, cognitive decline and spastic quadriparesis. Defects in PSAP saposin-C region are the cause of atypical Gaucher disease (AGD). Affected individuals have marked glucosylceramide accumulation in the spleen without having a deficiency of glucosylceramide-beta glucosidase characteristic of classic Gaucher disease, a lysosomal storage disorder. Defects in PSAP saposin-A region are the cause of atypical Krabbe disease (AKRD). AKRD is a disorder of galactosylceramide metabolism. AKRD features include progressive encephalopathy and abnormal myelination in the cerebral white matter resembling Krabbe disease. Defects in PSAP saposin-D region are found in a variant of Tay-Sachs disease (GM2-gangliosidosis). 3 isoforms of the human protein are produced by alternative splicing. Note: This description may include information from UniProtKB.
Chromosomal Location of Human Ortholog: 10q21-q22
Cellular Component: lysosomal lumen; extracellular space; mitochondrion; lysosomal membrane; extracellular region; integral to membrane
Molecular Function: protein binding; enzyme activator activity; lipid binding
Biological Process: positive regulation of catalytic activity; platelet activation; regulation of lipid metabolic process; platelet degranulation; sphingolipid metabolic process; regulation of MAPKKK cascade; glycosphingolipid metabolic process; blood coagulation; lipid transport
Reference #:  P07602 (UniProtKB)
Alt. Names/Synonyms: A1 activator; Cerebroside sulfate activator; Co-beta-glucosidase; Component C; CSAct; Dispersin; FLJ00245; GLBA; Glucosylceramidase activator; MGC110993; Proactivator polypeptide; prosaposin; Protein A; Protein C; PSAP; SAP; SAP-1; SAP-2; SAP1; Saposin-A; Saposin-B; Saposin-B-Val; Saposin-C; Saposin-D; Sphingolipid activator protein 1; Sphingolipid activator protein 2; sphingolipid activator protein-1; Sulfatide/GM1 activator
Gene Symbols: PSAP
Molecular weight: 58,113 Da
Basal Isoelectric point: 5.06  Predict pI for various phosphorylation states
Select Structure to View Below

PSAP

Protein Structure Not Found.


STRING  |  Wikipedia  |  Reactome  |  neXtProt  |  Protein Atlas  |  BioGPS  |  DISEASE  |  Scansite  |  Pfam  |  RCSB PDB  |  Phospho3D  |  Phospho.ELM  |  Source  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 1 K143-ub NLCESLQkHLAELNH
0 1 K152-ub LAELNHQkQLESNKI
0 1 T165-p KIPELDMtEVVAPFM
0 1 Y180-p ANIPLLLyPQDGPRs
0 1 S187-p yPQDGPRsKPQPKDN
0 1 K303-ub LELVEPIkKHEVPAK
0 1 K323-ub EVCEFLVkEVTKLID
0 1 T397-ga GTRLPALtVHVtQPK
0 1 T401-ga PALtVHVtQPKDGGF
0 2 K413-ac GGFCEVCkKLVGyLD
0 1 Y418-p VCkKLVGyLDRNLEK
0 1 Y447 CSFLPDPYQkQCDQF
0 1 K449-ub FLPDPYQkQCDQFVA
  mouse

 
E143 NLCQSLQEYLAEQNQ
K151 YLAEQNQKQLESNKI
A164 KIPEVDMARVVAPFM
Y179 SNIPLLLYPQDHPRS
S186 YPQDHPRSQPQPKAN
E305 LEMMDPYEQNLVQAH
N325 QTCQFVMNKFSELIV
P430 QPKQSALPAHVPPQK
P434 SALPAHVPPQKNGGF
K446 GGFCEVCKKLVLYLE
Y451 VCKKLVLYLEHNLEK
Y480 CSFLPDPYQKQCDDF
K482 FLPDPYQKQCDDFVA
  rat

 
E143 NLCQSLQEYLAEQNQ
R151 YLAEQNQRQLESNKI
A164 KIPEVDLARVVAPFM
Y179 SNIPLLLYPQDRPRS
S186 YPQDRPRSQPQPKAN
E302 LELTDPYEQDVIQAQ
R322 QVCQLVMRKLSELII
R427 EPKQSALRAHVPPQK
P431 SALRAHVPPQKNGGF
K443 GGFCEVCKKLVIYLE
Y448 VCKKLVIYLEHNLEK
Y477-p CSFLPDPyQKQCDEF
K479 FLPDPyQKQCDEFVA
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.